Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04835220
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-28
First Post:
2021-04-02
Brief Title:
Trial of Oral Lenalidomide Stewardship Program for Veterans
Sponsor:
WG Bill Hefner Medical Center
Organization:
WG Bill Hefner Medical Center
Study Overview
Official Title:
Trial of Oral Lenalidomide Stewardship Program for Veterans
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To address the challenge of oral chemotherapy stewardship in the Veteran population this study outlines the implementation and evaluation of a pilot program for the delivery and management of lenalidomide to increase the adherence rates Our goal is to utilize a team-based multi-disciplinary approach using existing technological resources such as the tele-oncology program at the Salisbury VA and other VA medical centers to provide cancer care that is safe effective compassionate and cost-effective Subject will be prescribed a Lenalidomide based therapy per standard of care Eligibility is based only on a prescription for Lenalidomide and is independent of any other concurrent treatments for myeloma The objectives are as followed 1 To describe the demographics and baseline clinical characteristics of veterans with newly diagnosed multiple myeloma treated with oral lenalidomide 2 To evaluate the impact of the stewardship program intervention on the adherence to oral lenalidomide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None